◀ Back to JUN
JUN — MYD88
Text-mined interactions from Literome
Chandrasekar et al., J Biol Chem 2005
:
Src kinase inhibitors PP1 and PP2, phosphatidylinositol 3-kinase (PI3K) inhibitors wortmannin and LY294002, Akt inhibitor, the c-Jun N-terminal kinase (JNK) inhibitor SP600125, antisense JNK and dominant negative
MyD88 , interleukin-1 receptor associated kinase ( IRAK)-1, IRAK4, and phosphatidylinositol 3-kinase expression all
attenuated IL-18 mediated
AP-1 binding and reporter activity, CXCL16 promoter-reporter activity, and CXCL16 expression
Ben Mkaddem et al., Cell Death Differ 2010
(Reperfusion Injury) :
In this study we show that TLR4 mediates
MyD88 dependent
activation of TNF receptor associated factor 2, apoptosis signal regulating kinase 1 ( ASK1 ), and
Jun N-terminal kinase (JNK) and p38 MAP kinases in ischemic reperfused kidneys and posthypoxic renal tubule epithelial cells ( RTECs )
Burns et al., J Biol Chem 1998
:
Overexpression of
MyD88 induces activation of the
c-Jun N-terminal kinase (JNK) and the transcription factor NF-kappaB through its DD